⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

April 30, 2018British journal of surgeryOpen Access

Meta-analysis comparing upfront surgery with neoadjuvant treatment in patients with resectable or borderline resectable pancreatic cancer

Eva Versteijne Jantien A. Vogel Marc G. Besselink Olivier R. Busch Johanna W. Wilmink Joost G. Daams Casper H.J. van Eijck Bas Groot Koerkamp C. Rasch Geertjan van Tienhoven

View Full Paper

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

Neoadjuvant treatment appears to improve overall survival by intention to treat, despite lower overall resection rates for resectable or borderline resectable pancreatic cancer. PROSPERO registration number: CRD42016049374.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Versteijne et al. (2018) studied this question.

synapsesocial.com/papers/69d8b3e88cb8f39931ae39d9 https://doi.org/10.1002/bjs.10870

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trialHuman Clinical Trial · 2017 · 1,941 citations
2CONKO-005: Adjuvant Chemotherapy With Gemcitabine Plus Erlotinib Versus Gemcitabine Alone in Patients After R0 Resection of Pancreatic Cancer: A Multicenter Randomized Phase III TrialRCT · 2017 · 292 citations
3The Impact of Curative Intent Surgery on the Survival of Pancreatic Cancer Patients: A U.S. Population-Based StudyCohort Study · 2007 · 132 citations
4The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaborationMeta-Analysis · 2009 · 17,721 citations
5The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsRisk Assessment · 2011 · 33,817 citations
6Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection PercentagesMeta-Analysis · 2010 · 1,554 citations
7Neoadjuvant chemoradiation therapy with gemcitabine/cisplatin and surgery versus immediate surgery in resectable pancreatic cancerCohort Study · 2014 · 324 citations
8Inverse Probability of Treatment Weighting Analysis of Upfront Surgery Versus Neoadjuvant Chemoradiotherapy Followed by Surgery for Pancreatic Adenocarcinoma with Arterial AbutmentOriginal Research · 2015 · 67 citations
9Shared data-driven risk language in surgical oncologyBritish journal of surgery · 2026
10Preoperative risk factor and risk score analysis to predict critical complications and death following pancreatoduodenetcomyBritish journal of surgery · 2026

More from British journal of surgery

More from Erasmus University Rotterdam

More from Amsterdam UMC Location University of Amsterdam